Laurel Wealth Advisors, Inc. Reata Pharmaceuticals Inc Transaction History

Laurel Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $107,997 - $467,918	-4,217 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$100.0 - $143.02 $25,000 - $35,755	250 Added 6.3%	4,217 $424,000
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $3,913 - $7,564	50 Added 1.28%	3,967 $561,000
Q1 2021 May 14, 2021	BUY	$94.25 - $132.81 $139,018 - $195,894	1,475 Added 60.4%	3,917 $391,000
Q4 2020 Mar 03, 2021	BUY	$102.03 - $184.62 $249,157 - $450,842	2,442 New	2,442 $302,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.